CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Antipsychotic medication adherence interventionbehavioral
Likely dose
Not stated in record
Key inclusion· 3
  • Medical chart diagnosis of schizophrenia or schizoaffective disorder
  • Currently prescribed outpatient antipsychotic medication (oral or depot formulation)
  • Adequate capacity to provide informed consent and understand the study
Key exclusion· 1
  • Significant cognitive impairment (BOMC score >10)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00144027
NCT00144027N/ACompleted

Patient-Centered Medication Adherence Intervention for Schizophrenia

US Department of Veterans Affairs·interventional·Posted Sep 2, 2005·Updated Apr 24, 2015

In Brief

A clinical study evaluating Antipsychotic medication adherence intervention for Schizophrenia. Completed, enrolled 75 participants across 1 site.

Detailed Summary

Efficacious antipsychotic medication treatments for schizophrenia are available; however , antipsychotic regimens frequently do not achieve their potential because of poor medication adherence. To date, medication adherence interventions have not been widely adopted or sustained in "real-world" practice settings. One reason for this is the substantial resource investment necessary to implement and sustain available interventions. In response to these problems, we developed a patient-centered adherence intervention based on patient-identified barriers, facilitators, and motivators (BFMs) for medication adherence. The intervention includes a BFM survey (checklist and preference weighting exercise to determine the patient's most important BFM) and a brief list of adherence enhancing suggestions (Options List) tailored to the patient-identified BFMs and compatible with CPRS. The long-term objective of this proposed research is to improve antipsychotic medication adherence and clinical outcomes for patients with schizophrenia using a cost-effective medication adherence intervention. The short-term objectives are to refine and test a patient-centered medication adherence intervention for VA patients with schizophrenia and specifically to: 1. Enhance the feasibility and acceptability of the BFM intervention by reducing the burden on patients and mental health providers through BFM checklist item reduction, provider intervention input, and patient intervention input. We hypothesize that our use of end-user input will result in at least 80% of intervention patients having documentation of a BFM intervention in CPRS. 2. Compare the effects of the BFM intervention versus usual care on changes in medication adherence and schizophrenia symptom severity. We hypothesize that the intervention will result in a) greater medication adherence and b) lower schizophrenia symptom severity than usual care. 3. Exploratory objective: compare the effects of the BFM intervention versus usual care on changes in patient health-related quality of life. We hypothesize that the intervention will result in greater health-related quality of life than usual care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 2, 2005
Enrollment StartDec 1, 2004
Primary CompletionJun 1, 2009
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 20.8 years ago

Interventions

Antipsychotic medication adherence interventionbehavioral

The medication adherence intervention will include using a computer to complete a brief set of questions related to medication adherence before mental health clinic visits.